PCBL Chemical Limited has officially announced the successful commissioning of a new specialty production line at its Mundra plant in Gujarat. This expansion marks a strategic development for the company, as it adds a gross capacity of 20,000 metric tonnes per annum (MTPA) to its existing infrastructure. With this addition, the company’s total specialty production capacity has reached 132 kilotonnes (KT) per annum.

Designed as a state-of-the-art facility, the new production line is specifically engineered to cater to high-growth, value-added application segments, including high-speed printing, digital printing, and ultraviolet (UV) printing. The company expects the output from this new line to ramp up progressively over the coming months. By increasing its footprint in these advanced printing solution markets, PCBL Chemical aims to strengthen its specialty portfolio and better address the evolving requirements of its global customer base.

As a prominent entity under the RP-Sanjiv Goenka Group, PCBL Chemical Limited has maintained a leading position in the carbon black industry for over six decades. Beyond its core manufacturing, the company has been diversifying its operations through strategic acquisitions, such as Aquapharm Chemicals, and partnerships like its joint venture with Kinaltek Pty and Nanovace Technologies. These efforts are designed to reduce reliance on traditional carbon black applications and pivot toward high-performance materials and specialty chemicals. During 2025, the company continued to prioritize sustainability, achieving milestones in carbon emission reduction and receiving various industry recognitions for operational excellence and safety standards.

In its most recent financial performance for the quarter ended March 31, 2026, the company reported a revenue of ₹2,070.72 Crores. While the company experienced an 11.23% increase in revenue on a quarterly basis, it saw a marginal decline of 1.73% when compared to the same period in the previous year. The net profit for the quarter stood at ₹40.25 Crores, reflecting a significant quarterly jump of 1882.76%, though it represents a 59.81% decrease compared to the corresponding quarter of the previous year. The company’s shareholder base includes major institutional investors, such as HDFC Asset Management Company Limited, SBI Life Insurance Company Limited, and Mahindra Manulife Investment Management, alongside its primary promoter entity, Rainbow Investments Limited.